CHUV
Les activités du CHUV
MENU
Centre de la prostate
Accueil > Recherche > Publications > Publications 2015

Publications de l'année 2015


Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.

De Bari B, Daidone A, Alongi F.

Crit Rev Oncol Hematol. 2015 Feb 17. pii: S1040-8428(15)00027-X. doi: 10.1016/j.critrevonc.2015.02.003. [Epub ahead of print] Review.

PMID:25819287

Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era.

D'Angelillo RM, Franco P, De Bari B, Fiorentino A, Arcangeli S, Alongi F.

Crit Rev Oncol Hematol. 2015 Feb;93(2):136-48. doi: 10.1016/j.critrevonc.2014.10.003. Epub 2014 Oct 17.

PMID:25459667

Technological aspects of delivering cryotherapy for prostate cancer.

Lau B, Shah TT, Valerio M, Hamid S, Ahmed HU, Arya M.

Expert Rev Med Devices. 2015 Mar;12(2):183-90. doi: 10.1586/17434440.2015.990377. Epub 2015 Jan 8.

PMID:25569713

Identifying the index lesion with template prostate mapping biopsies.

Valerio M, Anele C, Freeman A, Jameson C, Singh PB, Hu Y, Emberton M, Ahmed HU.

J Urol. 2015 Apr;193(4):1185-90. doi: 10.1016/j.juro.2014.11.015. Epub 2014 Nov 15.

PMID:25463987

Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.

Valerio M, Donaldson I, Emberton M, Ehdaie B, Hadaschik BA, Marks LS, Mozer P, Rastinehad AR, Ahmed HU.

Eur Urol. 2015 Jul;68(1):8-19. doi: 10.1016/j.eururo.2014.10.026. Review.

PMID:25454618

Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.

Valdagni R, Van Poppel H, Aitchison M, Albers P, Berthold D, Bossi A, Brausi M, Denis L, Drudge-Coates L, De Santis M, Feick G, Harrison C, Haustermans K, Hollywood D, Hoyer M, Hummel H, Mason M, Mirone V, Müller SC, Parker C, Saghatchian M, Sternberg CN, Tombal B, van Muilekom E, Watson M, Wesselmann S, Wiegel T, Magnani T, Costa A.

Crit Rev Oncol Hematol. 2015 Aug;95(2):133-43. doi: 10.1016/j.critrevonc.2015.05.014. Review.

PMID:26092320

Focal Therapy of Prostate Cancer Using Irreversible Electroporation.

Valerio M, Ahmed HU, Emberton M.

Tech Vasc Interv Radiol. 2015 Sep;18(3):147-52. doi: 10.1053/j.tvir.2015.06.005. Review.

PMID:26365544

Visually directed vs. software-based targeted biopsy compared to transperineal template mapping biopsy in the detection of clinically significant prostate cancer.

Valerio M, McCartan N, Freeman A, Punwani S, Emberton M, Ahmed HU.

Urol Oncol. 2015 Oct;33(10):424.e9-16. doi: 10.1016/j.urolonc.2015.06.012.

PMID:26195330

Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.

Panje CM, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera FG, Matzinger O, Plasswilm L, Putora PM.

Strahlenther Onkol. 2015 Oct;191(10):778-86. doi: 10.1007/s00066-015-0849-8.

PMID:25986251

Sharing uncertainties of prostate cancer screening

Selby K, Auer R, Valerio M, Jichlinski P, Cornuz J.

Rev Med Suisse. 2015 Nov 25;11(496):2216, 2218-20. French.

PMID:26742351

Methodological considerations in assessing the utility of imaging in early prostate cancer.

Valerio M, Willis S, van der Meulen J, Emberton M, Ahmed HU.

Curr Opin Urol. 2015 Nov;25(6):536-42. doi: 10.1097/MOU.0000000000000219. Review.

PMID:26383038

A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer.

Willis SR, van der Meulen J, Valerio M, Miners A, Ahmed HU, Emberton M.

Curr Opin Urol. 2015 Nov;25(6):483-9. doi: 10.1097/MOU.0000000000000220. Review.

PMID:26372036

Prostate biopsy: which strategy for which patient?

Burruni R, Cerantola Y, Meuwly JY, Tawadros T, Jichlinski P, Valerio M.

Rev Med Suisse. 2015 Dec 2;11(497):2288-90, 2292. French.

PMID:26785527